Study for the Effectiveness of Intensive Therapy for Diabetic Nephropathy in Unblinded, Randomized Intergroup Comparison Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs ACE inhibitors; Angiotensin receptor antagonists; HMG-CoA reductase inhibitors
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 23 Jul 2019 Biomarkers information updated
- 11 Jul 2007 The expected completion date for this trial is now 1 Jun 2011.
- 31 Oct 2006 New trial record.